{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:57:06Z","timestamp":1763629026594,"version":"3.45.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the self-financed scientific research project of Guangxi Zhuang Autonomous Region Health Commission","award":["No. Z-C20240911","No. Z-C20240915"],"award-info":[{"award-number":["No. Z-C20240911","No. Z-C20240915"]}]},{"name":"the project of improving the basic scientific research ability of young and middle-aged teachers in Guangxi universities","award":["No. 2025KY0519"],"award-info":[{"award-number":["No. 2025KY0519"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"DOI":"10.1007\/s13721-025-00648-5","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:52:29Z","timestamp":1763628749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated machine learning and multi-omics analysis develop a consensus necrosis induced by sodium overload-related signature for predicting prognosis and drug sensitivity for lung adenocarcinoma"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-0306","authenticated-orcid":false,"given":"Chunhong","family":"Li","sequence":"first","affiliation":[]},{"given":"Wangshang","family":"Qin","sequence":"additional","affiliation":[]},{"given":"Yuhua","family":"Mao","sequence":"additional","affiliation":[]},{"given":"Jiahua","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Shirong","family":"Nong","sequence":"additional","affiliation":[]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"648_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molcel.2023.11.040","volume":"84","author":"Y Ai","year":"2024","unstructured":"Ai Y, Meng Y, Yan B, Zhou Q, Wang X (2024) The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death. Mol Cell 84:170\u2013179. https:\/\/doi.org\/10.1016\/j.molcel.2023.11.040","journal-title":"Mol Cell"},{"key":"648_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"648_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/ng.3458","volume":"48","author":"MA Castro","year":"2016","unstructured":"Castro MA, de Santiago I, Campbell TM, Vaughn C, Hickey TE, Ross E, Tilley WD, Markowetz F, Ponder BA, Meyer KB (2016) Regulators of genetic risk of breast cancer identified by integrative network analysis. Nat Genet 48:12\u201321. https:\/\/doi.org\/10.1038\/ng.3458","journal-title":"Nat Genet"},{"key":"648_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, Hackl H, Trajanoski Z (2017) Pan-cancer Immunogenomic analyses reveal Genotype-Immunophenotype relationships and predictors of response to checkpoint Blockade. Cell Rep 18:248\u2013262. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019","journal-title":"Cell Rep"},{"key":"648_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.694071","volume":"9","author":"D Che","year":"2021","unstructured":"Che D, Wang M, Sun J, Li B, Xu T, Lu Y, Pan H, Lu Z, Gu X (2021) KRT6A promotes lung cancer cell growth and invasion through MYC-regulated pentose phosphate pathway. Front Cell Dev Biol 9:694071. https:\/\/doi.org\/10.3389\/fcell.2021.694071","journal-title":"Front Cell Dev Biol"},{"key":"648_CR6","doi-asserted-by":"publisher","first-page":"963220","DOI":"10.3389\/fendo.2022.963220","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Tang L, Huang W, Zhang Y, Abisola FH, Li L (2022) Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma. Front Endocrinol (Lausanne) 13:963220. https:\/\/doi.org\/10.3389\/fendo.2022.963220","journal-title":"Front Endocrinol (Lausanne)"},{"key":"648_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402703","volume":"11","author":"S Chen","year":"2024","unstructured":"Chen S, Tang Q, Hu M, Song S, Wu X, Zhou Y, Yang Z, Liao S, Zhou L, Wang Q, Liu H, Yang M, Chen ZS, Zhao W, He S, Zhou Z (2024) Loss of carbamoyl phosphate synthetase 1 potentiates hepatocellular carcinoma metastasis by reducing aspartate level. Adv Sci 11:e2402703. https:\/\/doi.org\/10.1002\/advs.202402703","journal-title":"Adv Sci"},{"key":"648_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, Ceccarelli M, Bontempi G, Noushmehr H (2016) TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44:e71. https:\/\/doi.org\/10.1093\/nar\/gkv1507","journal-title":"Nucleic Acids Res"},{"key":"648_CR9","doi-asserted-by":"publisher","unstructured":"Collisson EA, Campbell JD, Brooks AN, Berger AH, Lee W, Chmielecki J, Beer DG, Cope L, Creighton CJ, Danilova L, Ding L, Getz G, Hammerman PS, Hayes N, Hernandez D, B, Herman, JG, Heymach, JV, Jurisica, I, Kucherlapati R, Kwiatkowski, D et al (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511: 543\u2013550. https:\/\/doi.org\/10.1038\/nature13385","DOI":"10.1038\/nature13385"},{"key":"648_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00262-022-03251-z","volume":"72","author":"Y Feng","year":"2023","unstructured":"Feng Y, Tang L, Wang H, Liu Y, Yang S, Lin L, Hu X, Shi Y (2023) Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients. Cancer Immunol Immunother 72:449\u2013459. https:\/\/doi.org\/10.1007\/s00262-022-03251-z","journal-title":"Cancer Immunol Immunother"},{"key":"648_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-025-01841-3","author":"W Fu","year":"2025","unstructured":"Fu W, Wang J, Li T, Qiao Y, Zhang Z, Zhang X, He M, Su Y, Zhao Z, Li C, Xiao R, Han Y, Zhang S, Liu Z, Lin J, Chen G, Li Y, Zhong Q (2025) Persistent activation of TRPM4 triggers necrotic cell death characterized by sodium overload. Nat Chem Biol. https:\/\/doi.org\/10.1038\/s41589-025-01841-3","journal-title":"Nat Chem Biol"},{"key":"648_CR12","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1158\/0008-5472.Can-23-0157","volume":"83","author":"S Ghosh","year":"2023","unstructured":"Ghosh S, Yang R, Duraki D, Zhu J, Kim JE, Jabeen M, Mao C, Dai X, Livezey MR, Boudreau MW, Park BH, Nelson ER, Hergenrother PJ, Shapiro DJ (2023) Plasma membrane channel TRPM4 mediates immunogenic therapy-induced necrosis. Cancer Res 83:3115\u20133130. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0157","journal-title":"Cancer Res"},{"key":"648_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7298192","volume":"2022","author":"J Gong","year":"2022","unstructured":"Gong J, Gu J, Jiang L, Zhao D, Shao L, Chen X, Liu J (2022) Clinical study on the efficacy of bevacizumab in combination with pembrolizumab on cellular immune function in the treatment of driver gene-negative stage IV lung adenocarcinoma. J Oncol 2022:7298192. https:\/\/doi.org\/10.1155\/2022\/7298192","journal-title":"J Oncol"},{"key":"648_CR14","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1097\/cm9.0000000000003268","volume":"137","author":"L Guo","year":"2024","unstructured":"Guo L, Zhu C, Cai L, Zhang X, Fang Y, Chen H, Yang H (2024) Global burden of lung cancer in 2022 and projected burden in 2050. Chin Med J 137:2577\u20132582. https:\/\/doi.org\/10.1097\/cm9.0000000000003268","journal-title":"Chin Med J"},{"key":"648_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107402","volume":"165","author":"J Huang","year":"2023","unstructured":"Huang J, Zhang J, Zhang F, Lu S, Guo S, Shi R, Zhai Y, Gao Y, Tao X, Jin Z, You L, Wu J (2023) Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma. Comput Biol Med 165:107402. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107402","journal-title":"Comput Biol Med"},{"key":"648_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, Berent-Maoz B, Pang J, Chmielowski B, Cherry G, Seja E, Lomeli S, Kong X, Kelley MC, Sosman JA, Johnson DB, Ribas A, Lo RS (2016) Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165:35\u201344. https:\/\/doi.org\/10.1016\/j.cell.2016.02.065","journal-title":"Cell"},{"key":"648_CR17","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1172\/jci91095","volume":"127","author":"J Jeschke","year":"2017","unstructured":"Jeschke J, Bizet M, Desmedt C, Calonne E, Dedeurwaerder S, Garaud S, Koch A, Larsimont D, Salgado R, Van den Eynden G, Willard Gallo K, Bontempi G, Defrance M, Sotiriou C, Fuks F (2017) DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. J Clin Investig 127:3090\u20133102. https:\/\/doi.org\/10.1172\/jci91095","journal-title":"J Clin Investig"},{"key":"648_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J, Freeman GJ, Brown MA, Wucherpfennig KW, Liu XS (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24:1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1","journal-title":"Nat Med"},{"key":"648_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12159-9","volume":"10","author":"H Jung","year":"2019","unstructured":"Jung H, Kim HS, Kim JY, Sun JM, Ahn JS, Ahn MJ, Park K, Esteller M, Lee SH, Choi JK (2019) DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nat Commun 10:4278. https:\/\/doi.org\/10.1038\/s41467-019-12159-9","journal-title":"Nat Commun"},{"issue":"1","key":"648_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05385-7","volume":"12","author":"B Lane","year":"2022","unstructured":"Lane B, Khan MT, Choudhury A, Salem A, West CML (2022) Development and validation of a hypoxia-associated signature for lung adenocarcinoma. Sci Rep 12(1):1290. https:\/\/doi.org\/10.1038\/s41598-022-05385-7","journal-title":"Sci Rep"},{"key":"648_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP (2023) The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol 20:624\u2013639. https:\/\/doi.org\/10.1038\/s41571-023-00798-3","journal-title":"Nat Rev Clin Oncol"},{"key":"648_CR22","doi-asserted-by":"publisher","first-page":"39572","DOI":"10.18632\/oncotarget.9138","volume":"7","author":"FF Li","year":"2016","unstructured":"Li FF, Yan P, Zhao ZX, Liu Z, Song DW, Zhao XW, Wang XS, Wang GY, Liu SL (2016) Polymorphisms in the CHIT1 gene: associations with colorectal cancer. Oncotarget 7:39572\u201339581. https:\/\/doi.org\/10.18632\/oncotarget.9138","journal-title":"Oncotarget"},{"key":"648_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/17588359241302021","volume":"16","author":"MSC Li","year":"2024","unstructured":"Li MSC, Chan ALS, Mok KKS, Chan LL, Mok TSK (2024) Next-generation immunotherapy: igniting new hope for lung cancer. Ther Adv Med Oncol 16:17588359241302021. https:\/\/doi.org\/10.1177\/17588359241302021","journal-title":"Ther Adv Med Oncol"},{"key":"648_CR24","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu CJ, Hu FF, Xia MX, Han L, Zhang Q, Guo AY (2018) GSCALite: a web server for gene set cancer analysis. Bioinformatics 34:3771\u20133772. https:\/\/doi.org\/10.1093\/bioinformatics\/bty411","journal-title":"Bioinformatics"},{"key":"648_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, Olszewski K, Horbath A, Chen X, Lei G, Mao C, Wu S, Zhuang L, Poyurovsky MV, James You M, Hart T, Billadeau DD, Chen J, Gan B (2023) Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol 25:404\u2013414. https:\/\/doi.org\/10.1038\/s41556-023-01091-2","journal-title":"Nat Cell Biol"},{"key":"648_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ins.2013.07.007","volume":"250","author":"V L\u00f3pez","year":"2013","unstructured":"L\u00f3pez V, Fern\u00e1ndez A, Garc\u00eda S, Palade V, Herrera F (2013) An insight into classification with imbalanced data: empirical results and current trends on using data intrinsic characteristics. Inf Sci 250:113\u2013141. https:\/\/doi.org\/10.1016\/j.ins.2013.07.007","journal-title":"Inf Sci"},{"key":"648_CR27","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","volume":"36","author":"X Lu","year":"2021","unstructured":"Lu X, Meng J, Zhou Y, Jiang L, Yan F (2021) MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics 36:5539\u20135541. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1018","journal-title":"Bioinformatics"},{"key":"648_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(24)00428-4","author":"G Luo","year":"2025","unstructured":"Luo G, Zhang Y, Rumgay H, Morgan E, Langselius O, Vignat J, Colombet M, Bray F (2025) Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study. Lancet Respir Med. https:\/\/doi.org\/10.1016\/s2213-2600(24)00428-4","journal-title":"Lancet Respir Med"},{"key":"648_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS (2021) Oncopredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab260","journal-title":"Brief Bioinform"},{"key":"648_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.823618","volume":"13","author":"H Mamdani","year":"2022","unstructured":"Mamdani H, Matosevic S, Khalid AB, Durm G, Jalal SI (2022) Immunotherapy in lung cancer: current landscape and future directions. Front Immunol 13:823618. https:\/\/doi.org\/10.3389\/fimmu.2022.823618","journal-title":"Front Immunol"},{"key":"648_CR31","doi-asserted-by":"publisher","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE, Koeppen III, Astarita H, Cubas JL, Jhunjhunwala R, Banchereau S, Yang R, Guan Y, Chalouni Y, Ziai C, \u015eenbabao\u011flu J, Santoro Y, Sheinson S, Hung D, J et al (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554: 544\u2013548. https:\/\/doi.org\/10.1038\/nature25501","DOI":"10.1038\/nature25501"},{"key":"648_CR32","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28:1747\u20131756. https:\/\/doi.org\/10.1101\/gr.239244.118","journal-title":"Genome Res"},{"key":"648_CR33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.annonc.2024.10.006","volume":"35","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, Peters S, Mok TS, Lam S, Yang PC, Aggarwal C, Brahmer J, Dziadziuszko R, Felip E, Ferris A, Forde PM, Gray J, Gros L, Halmos B, Herbst R, J\u00e4nne PA, Johnson BE, Kelly K, Leighl NB, Liu S et al (2024) Lung cancer research and treatment: global perspectives and strategic calls to action. Ann Oncol 35:1088\u20131104. https:\/\/doi.org\/10.1016\/j.annonc.2024.10.006","journal-title":"Ann Oncol"},{"key":"648_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002891","author":"MV Negrao","year":"2021","unstructured":"Negrao MV, Skoulidis F, Montesion M, Schulze K, Bara I, Shen V, Xu H, Hu S, Sui D, Elamin YY, Le X, Goldberg ME, Murugesan K, Wu CJ, Zhang J, Barreto DS, Robichaux JP, Reuben A, Cascone T, Gay CM et al (2021) Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-002891","journal-title":"J Immunother Cancer"},{"key":"648_CR35","doi-asserted-by":"publisher","first-page":"i197","DOI":"10.1093\/bioinformatics\/btv268","volume":"31","author":"F Petralia","year":"2015","unstructured":"Petralia F, Wang P, Yang J, Tu Z (2015) Integrative random forest for gene regulatory network inference. Bioinf (Oxford England) 31:i197\u2013205. https:\/\/doi.org\/10.1093\/bioinformatics\/btv268","journal-title":"Bioinf (Oxford England)"},{"key":"648_CR36","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.Can-12-1370","volume":"72","author":"WC Reinhold","year":"2012","unstructured":"Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, Doroshow J, Pommier Y (2012) Cellminer: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res 72:3499\u20133511. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-1370","journal-title":"Cancer Res"},{"key":"648_CR37","doi-asserted-by":"publisher","unstructured":"Riaz N, Havel JJ, Makarov V, Desrichard A, Urba WJ, Sims JS, Hodi FS, Mart\u00edn-Algarra S, Mandal R, Sharfman WH, Bhatia S, Hwu WJ, Gajewski TF, Slingluff CL Jr., Chowell D, Kendall SM, Chang H, Shah R, Kuo F, Morris, LGT et al (2017) Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell 171: 934\u2013949.e916. https:\/\/doi.org\/10.1016\/j.cell.2017.09.028","DOI":"10.1016\/j.cell.2017.09.028"},{"key":"648_CR38","doi-asserted-by":"publisher","unstructured":"Rosenberg JE, Hoffman-Censits J, Powles T, van der Heijden MS, Balar AV, Necchi A, Dawson N, O\u2019Donnell PH, Balmanoukian A, Loriot Y, Srinivas S, Retz MM, Grivas P, Joseph RW, Galsky MD, Fleming MT, Petrylak DP, Perez-Gracia JL, Burris HA, Castellano, D et al (2016) Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet (London, England) 387: 1909\u20131920. https:\/\/doi.org\/10.1016\/s0140-6736(16)00561-4","DOI":"10.1016\/s0140-6736(16)00561-4"},{"key":"648_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","journal-title":"CA Cancer J Clin"},{"key":"648_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57364-x","volume":"16","author":"H Su","year":"2025","unstructured":"Su H, Chen L, Wu J, Cheng Z, Li J, Ren Y, Xu J, Dang Y, Zheng M, Cao Y, Gao J, Dai C, Hu X, Xie H, Chen J, Luo T, Zhu J, Wu C, Sha W, Chen C et al (2025) Proteogenomic characterization reveals tumorigenesis and progression of lung cancer manifested as subsolid nodules. Nat Commun 16:2414. https:\/\/doi.org\/10.1038\/s41467-025-57364-x","journal-title":"Nat Commun"},{"key":"648_CR41","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1002\/cam4.3240","volume":"9","author":"S Sun","year":"2020","unstructured":"Sun S, Guo W, Wang Z, Wang X, Zhang G, Zhang H, Li R, Gao Y, Qiu B, Tan F, Gao Y, Xue Q, Gao S, He J (2020) Development and validation of an immune-related prognostic signature in lung adenocarcinoma. Cancer Med 9:5960\u20135975. https:\/\/doi.org\/10.1002\/cam4.3240","journal-title":"Cancer Med"},{"key":"648_CR42","doi-asserted-by":"publisher","unstructured":"Tong X, Patel AS, Kim E, Li H, Chen Y, Li S, Liu S, Dilly J, Kapner KS, Zhang N, Xue Y, Hover L, Mukhopadhyay S, Sherman F, Myndzar K, Sahu P, Gao Y, Li F, Li F, Fang, Z et al (2024) Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer. Cancer cell 42: 413\u2013428.e417. https:\/\/doi.org\/10.1016\/j.ccell.2024.01.012","DOI":"10.1016\/j.ccell.2024.01.012"},{"key":"648_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G (2021a) Clusterprofiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb) 2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","journal-title":"Innovation (Camb)"},{"key":"648_CR44","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1002\/hep.32088","volume":"74","author":"T Wu","year":"2021","unstructured":"Wu T, Luo G, Lian Q, Sui C, Tang J, Zhu Y, Zheng B, Li Z, Zhang Y, Zhang Y, Bao J, Hu J, Shen S, Yang Z, Wu J, Wang K, Zhao Y, Yang S, Wang S, Qiu X et al (2021b) Discovery of a carbamoyl phosphate synthetase 1-deficient HCC subtype with therapeutic potential through integrative genomic and experimental analysis. Hepatology 74:3249\u20133268. https:\/\/doi.org\/10.1002\/hep.32088","journal-title":"Hepatology"},{"issue":"3","key":"648_CR45","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.21037\/tcr-23-1557","volume":"13","author":"T Xin","year":"2024","unstructured":"Xin T, Zheng C, Li GZ, Xu X, Zhang J, Jia C, Jing P, Lu Q (2024) Comprehensive analysis of exosome gene LYPD3 and prognosis\/immune cell infiltration in lung cancer. Transl Cancer Res 13(3):1394\u20131405. https:\/\/doi.org\/10.21037\/tcr-23-1557","journal-title":"Transl Cancer Res"},{"key":"648_CR46","doi-asserted-by":"publisher","unstructured":"Xu JY, Zhang C, Wang X, Zhai L, Ma Y, Mao Y, Qian K, Sun C, Liu Z, Jiang S, Wang M, Feng L, Zhao L, Liu P, Wang B, Zhao X, Xie H, Yang X, Zhao L, Chang, Y et al (2020) Integrative Proteomic Characterization of Human Lung Adenocarcinoma. Cell 182: 245\u2013261.e217. https:\/\/doi.org\/10.1016\/j.cell.2020.05.043","DOI":"10.1016\/j.cell.2020.05.043"},{"key":"648_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D (2024) A guide to cell death pathways. Nat Rev Mol Cell Biol 25:379\u2013395. https:\/\/doi.org\/10.1038\/s41580-023-00689-6","journal-title":"Nat Rev Mol Cell Biol"},{"key":"648_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, Zhou R, Qiu W, Huang N, Sun L, Li X, Bin J, Liao Y, Shi M, Liao W (2021) IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol 12:687975. https:\/\/doi.org\/10.3389\/fimmu.2021.687975","journal-title":"Front Immunol"},{"key":"648_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05740-0","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Trojel-Hansen C, Wang J, Zhang Z, Wang X, Qiao Y, Jiao H, Michaud M, Kepp O, J\u00e4\u00e4ttel\u00e4 M, Kroemer G, Zhong Q (2023) Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells. Cell Death Dis 14:238. https:\/\/doi.org\/10.1038\/s41419-023-05740-0","journal-title":"Cell Death Dis"},{"key":"648_CR50","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00011-024-01871-y","volume":"73","author":"L Zhang","year":"2024","unstructured":"Zhang L, Zhang X, Guan M, Zeng J, Yu F, Lai F (2024) Identification of a novel ADCC-related gene signature for predicting the prognosis and therapy response in lung adenocarcinoma. Inflamm Res 73:841\u2013866. https:\/\/doi.org\/10.1007\/s00011-024-01871-y","journal-title":"Inflamm Res"},{"key":"648_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/mdr2.70000","author":"J Zhang","year":"2025","unstructured":"Zhang J, Li H, Tao W, Zhou J (2025) GseaVis: an R package for enhanced visualization of gene set enrichment analysis in biomedicine. Med Res. https:\/\/doi.org\/10.1002\/mdr2.70000","journal-title":"Med Res"},{"key":"648_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102966","volume":"68","author":"D Zhao","year":"2023","unstructured":"Zhao D, Meng Y, Dian Y, Zhou Q, Sun Y, Le J, Zeng F, Chen X, He Y, Deng G (2023) Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy. Redox Biol 68:102966. https:\/\/doi.org\/10.1016\/j.redox.2023.102966","journal-title":"Redox Biol"},{"key":"648_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01545-6","volume":"17","author":"S Zhou","year":"2024","unstructured":"Zhou S, Liu J, Wan A, Zhang Y, Qi X (2024) Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis. J Hematol Oncol 17:22. https:\/\/doi.org\/10.1186\/s13045-024-01545-6","journal-title":"J Hematol Oncol"},{"key":"648_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0314-1","volume":"6","author":"J Zhu","year":"2018","unstructured":"Zhu J, Armstrong AJ, Friedlander TW, Kim W, Pal SK, George DJ, Zhang T (2018) Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond. J Immunother Cancer 6:4. https:\/\/doi.org\/10.1186\/s40425-018-0314-1","journal-title":"J Immunother Cancer"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00648-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-025-00648-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00648-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:52:30Z","timestamp":1763628750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-025-00648-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1007\/s13721-025-00648-5","relation":{},"ISSN":["2192-6670"],"issn-type":[{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the sequencing data from the TCGA and GEO databases are publicly available, further approval by an ethics committee was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}